A01K 67/0271
Chimeric vertebrates
Official title: Chimeric vertebrates, e.g. comprising exogenous cells
A01K67/0271 (Chimeric vertebrates) appears on 714 US grants and 1,148 published applications in this corpus.
Search patents in A01K- Granted patents
- 714
- Published applications
- 1,148
- Assignees
- 571
- Inventors
- 2,027
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 6 | 0 |
| 1996 | 16 | 0 |
| 1997 | 19 | 0 |
| 1998 | 23 | 0 |
| 1999 | 18 | 0 |
| 2000 | 20 | 0 |
| 2001 | 27 | 16 |
| 2002 | 24 | 51 |
| 2003 | 24 | 52 |
| 2004 | 17 | 58 |
| 2005 | 19 | 43 |
| 2006 | 23 | 66 |
| 2007 | 29 | 63 |
| 2008 | 17 | 40 |
| 2009 | 25 | 55 |
| 2010 | 28 | 44 |
| 2011 | 28 | 48 |
| 2012 | 17 | 42 |
| 2013 | 25 | 38 |
| 2014 | 18 | 52 |
| 2015 | 26 | 52 |
| 2016 | 31 | 51 |
| 2017 | 26 | 52 |
| 2018 | 22 | 48 |
| 2019 | 29 | 47 |
| 2020 | 26 | 45 |
| 2021 | 25 | 39 |
| 2022 | 22 | 36 |
| 2023 | 28 | 27 |
| 2024 | 21 | 34 |
| 2025 | 15 | 26 |
| 2026 | 15 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetically modified non-human animals expressing human EPO4 Aug 2026US 12,696,884 B2Institute for Research in Biomedicine (IRB)
- Formation of three-dimensional organ from pluripotent stem cells4 Aug 2026US 12,698,480 B2Public University Corporation Yokohama City University
- Immune cells derived from induced pluripotent stem cell14 Jul 2026US 12,680,075 B2Children's Medical Center Corporation
- Genetically modified non-human animals and methods of use thereof7 Jul 2026US 12,672,643 B2Institute for Research in Biomedicine (IRB)
- Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder7 Jul 2026US 12,673,119 B2University of Rochester
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse8 Oct 2026US 2026/0308532 A1Fred Hutchinson Cancer Center
- Nf2-associated meningioma model24 Sep 2026US 2026/0286314 A1
- Organ regeneration method utilizing blastocyst complementation3 Sep 2026US 2026/0256122 A1The University of Tokyo
- Cancer model animal and method for producing same13 Aug 2026US 2026/0231913 A1Orbio Corporation
Most cited
By later US patents
- Generation of Xenogenetic antibodies561US 6,162,963 AAbgenix, Inc. · 2000
- Generation of xenogeneic antibodies295US 6,673,986 B1Abgenix, Inc. · 2004
- Transgenic swine compositions and methods282US 5,942,435 ABiotechnology Research and Development Corporation · 1999
- Adenovirus vectors for gene therapy278US 5,585,362 AThe Regents of the University of Michigan · 1996
- Homologous recombination for universal donor cells and chimeric mammalian hosts232US 5,413,923 ACell Genesys, Inc. · 1995